by Doug Bonness | Sep 23, 2020 | Cancer, Diabetes, Health, Heart Disease, MD DiabeticPro, MD Heartpro, Pharmacogenomics
~As social distancing measures have decreased, demand for medical tests other than COVID-19 increase~ GREENVILLE, SC September 23, 2020 – At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits...
by Doug Bonness | Mar 14, 2016 | Pharmacogenomics
Advancements in medical technology are occurring in the field of DNA testing. Technological advancements are making genomic testing faster and more cost-effective. Now these genotype tests can be done simply through a quick swab of a patient’s cheek and physicians can...
by Doug Bonness | Jan 28, 2016 | Pharmacogenomics
Since 2007, when the FDA acknowledged that a blood-thinning drug’s effectiveness (or lack of) could be determined by how a person’s unique genetic structure responded to dosage, the medical field has been questioning its trial-by-error methodology....
